ACS Omega,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 16, 2024
The
use
of
viral
protein
inhibitors
has
shown
to
be
insufficiently
effective
in
the
case
highly
variable
SARS-CoV-2.
In
this
work,
we
examined
possibility
designing
agents
that
bind
a
conserved
region
coronavirus
(+)RNA.
We
demonstrated
while
design
antisense
RNAs
is
based
on
complementary
interaction
nitrogenous
bases,
it
possible
semirigid
docking
methods
unnatural
peptide
nucleic
acids.
transition
from
N-(2-aminoethyl)glycine
chain
more
conformationally
rigid
piperidine-containing
backbone
allowed
us
significantly
increase
affinity
structures
target
RNA.
Journal of Medicinal Chemistry,
Journal Year:
2023,
Volume and Issue:
67(1), P. 492 - 512
Published: Dec. 20, 2023
Herein,
modifications
to
the
previously
reported
BIBR1591
were
conducted
obtain
bioisosteric
candidates
with
improved
activities.
The
%
inhibition
of
newly
afforded
against
telomerase
target
was
investigated.
Notably,
6f
achieved
superior
(63.14%)
compared
BIBR1532
and
(69.64
51.58%,
respectively).
In
addition,
8a
8b
showed
comparable
promising
58.65
55.57%,
respectively,
which
recorded
be
frontier
that
BIBR1591.
6f,
8a,
tested
five
cancer
cell
lines
related
lung
liver
subtypes.
Moreover,
examined
on
both
cycle
progression
apoptosis
induction
in
HuH7
cells.
Furthermore,
vivo
antitumor
activity
further
assessed
female
mice
solid
Ehrlich
carcinoma.
molecular
docking
dynamics
simulations
carried
out.
Collectively,
could
considered
potential
new
inhibitors
subjected
investigation
and/or
optimization.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Aug. 23, 2024
Abstract
Even
though
legumes
are
valuable
medicinal
plants
with
edible
seeds
that
extensively
consumed
worldwide,
there
is
little
information
available
on
the
metabolic
variations
between
different
dietary
beans
and
their
influence
as
potential
anti-cholinesterase
agents.
High-resolution
liquid
chromatography
coupled
mass
spectrometry
in
positive
negative
ionization
modes
combined
multivariate
analysis
were
used
to
explore
differences
profiles
of
five
commonly
seeds,
fava
bean,
black-eyed
pea,
kidney
red
lentil,
chickpea.
A
total
139
metabolites
from
various
classes
identified
including
saponins,
alkaloids,
phenolic
acids,
iridoids,
terpenes.
Chickpea
showed
highest
antioxidant
effects,
followed
by
beans.
Supervised
unsupervised
chemometric
determined
species
could
be
distinguished
discriminatory
metabolites.
The
major
pathways
also
studied.
Glycerophospholipid
metabolism
was
most
significantly
enriched
KEGG
pathway.
Pearson’s
correlation
pinpointed
18
positively
correlated
activity.
Molecular
docking
biomarkers
active
sites
acetyl-
butyryl-cholinesterase
enzymes
revealed
promising
binding
scores,
validating
results.
present
study
will
add
metabolomic
nutritional
value
advocate
inclusion
anti-Alzheimer’s
formulations.
Future Medicinal Chemistry,
Journal Year:
2023,
Volume and Issue:
15(19), P. 1773 - 1790
Published: Oct. 1, 2023
Aim:
Our
objective
was
to
design
and
synthesize
a
new
range
of
pyrazolopyrimidines
while
maintaining
the
key
pharmacophoric
features
EGFR
tyrosine
kinase
inhibitors.
Materials
&
methods:
Percentage
inhibition
in
14
human
cancer
cell
lines
IC50
values
were
recorded.
Compounds
6c,
7e
7f
examined
against
both
wild
mutant
(T790M)
subtypes.
Apoptosis
markers,
cycle
arrest,
apoptosis
assay
molecular
docking
performed.
Results:
demonstrated
superior
inhibitory
potentials
A
study
showed
that
compounds
6c
had
best
fit.
Conclusion:
The
designed
candidates
potential
as
promising
EGFR-T790M
inhibitors
agrees
with
proposed
rationale.
Drug Development Research,
Journal Year:
2024,
Volume and Issue:
85(4)
Published: May 15, 2024
Abstract
Although
various
approaches
exist
for
treating
cancer,
chemotherapy
continues
to
hold
a
prominent
role
in
the
management
of
this
disease.
Besides,
microtubules
serve
as
vital
component
cellular
skeleton,
playing
pivotal
process
cell
division
making
it
an
attractive
target
cancer
treatment.
Hence,
scope
work
was
adapted
design
and
synthesize
new
anti‐tubulin
tetrabromophthalimide
hybrids
(
3
‐
17
)
with
colchicine
binding
site
(CBS)
inhibitory
potential.
The
conducted
vitro
studies
showed
that
compound
16
displayed
lowest
IC
50
values
(11.46
µM)
at
FaDu
lines,
whereas
exhibited
value
(13.62
PC3
line.
However,
7b
(11.45
MDA‐MB‐468
Moreover,
observed
be
superior
antitumor
candidate
against
all
three
tested
lines
(MDA‐MB‐468,
PC3,
FaDu)
17.22,
13.15,
13.62
µM,
respectively.
In
addition,
well‐established
upregulation
apoptotic
markers
(Caspases
3,
7,
8,
9,
Bax,
P53).
induced
downregulation
antiapoptotic
(MMP2,
MMP9,
BCL‐2).
Furthermore,
inhibition
assay
compounds
15a
particularly
significant
potentials,
23.07
4.25
respectively,
compared
colchicine,
which
had
3.89
µM.
Additionally,
cycle
analysis
conducted,
showing
could
prompt
arrest
both
G0‐G1
G2‐M
phases.
On
other
hand,
molecular
docking
approach
applied
investigate
interactions
examined
candidates
towards
CBS
β‐tubulin
subunit.
Thus,
synthesized
can
regarded
outstanding
anticancer
activity.
Metabolites,
Journal Year:
2022,
Volume and Issue:
12(11), P. 1109 - 1109
Published: Nov. 13, 2022
The
anti-MERS-CoV
activities
of
three
medicinal
plants
(Azadirachta
indica,
Artemisia
judaica,
and
Sophora
tomentosa)
were
evaluated.
highest
viral
inhibition
percentage
(96%)
was
recorded
for
S.
tomentosa.
Moreover,
the
mode
action
both
tomentosa
A.
judaica
showed
99.5%
92%
inhibition,
respectively,
with
virucidal
as
main
action.
Furthermore,
anti-SARS-CoV-2
measured.
Notably,
activity
very
high
(100%)
slightly
lower
(96%).
Therefore,
phytochemical
investigation
promising
L.
led
to
isolation
structural
identification
nine
compounds
(1−9).
Then,
CC50
IC50
values
isolated
against
SARS-CoV-2
Compound
4
(genistein
4’-methyl
ether)
achieved
superior
an
value
2.13
µm.
Interestingly,
that
adsorption
mechanisms
effective.
Additionally,
MERS-CoV
found
be
1.01
3.11
µg/mL,
respectively.
In
addition,
all
subjected
two
separate
molecular
docking
studies
spike
(S)
protease
(Mpr°)
receptors
SARS-CoV-2.
Molecules,
Journal Year:
2023,
Volume and Issue:
28(5), P. 2356 - 2356
Published: March 3, 2023
The
COVID-19
pandemic
has
given
a
strong
impetus
to
the
search
for
antivirals
active
on
SARS-associated
coronaviruses.
Over
these
years,
numerous
vaccines
have
been
developed
and
many
of
are
effective
clinically
available.
Similarly,
small
molecules
monoclonal
antibodies
also
approved
by
FDA
EMA
treatment
SARS-CoV-2
infection
in
patients
who
could
develop
severe
form
COVID-19.
Among
available
therapeutic
tools,
molecule
nirmatrelvir
was
2021.
It
is
drug
capable
binding
Mpro
protease,
an
enzyme
encoded
viral
genome
essential
intracellular
replication.
In
this
work,
virtual
screening
focused
library
β-amido
boronic
acids,
we
designed
synthesized
compounds.
All
them
were
biophysically
tested
microscale
thermophoresis,
attaining
encouraging
results.
Moreover,
they
displayed
protease
inhibitory
activity,
as
demonstrated
performing
enzymatic
assays.
We
confident
that
study
will
pave
way
design
new
drugs
potentially
useful
infection.